MEI Pharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
MEI Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2012 to Q3 2024.
  • MEI Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$8.01M, a 114% decline year-over-year.
  • MEI Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$46.6M, a 213% decline year-over-year.
  • MEI Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $17.8M.
  • MEI Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$31.8M, a 41% increase from 2022.
  • MEI Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$54M, a 31.7% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$46.6M -$8.01M -$64.4M -114% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $17.8M -$18.4M -$8.38M -83.5% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-19
Q1 2024 $26.2M -$9.13M +$6.31M +40.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $19.8M -$11.1M -$21.3M -208% Oct 1, 2023 Dec 31, 2023 10-Q 2024-05-09
Q3 2023 $41.2M $56.4M +$73M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$31.8M -$10M +$5.58M +35.7% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-19
Q1 2023 -$37.4M -$15.4M -$6.71M -76.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$30.7M $10.3M +$22.4M Oct 1, 2022 Dec 31, 2022 10-Q 2024-05-09
Q3 2022 -$53.1M -$16.6M +$886K +5.06% Jul 1, 2022 Sep 30, 2022 10-Q 2024-05-09
Q2 2022 -$54M -$15.6M -$7.55M -93.6% Apr 1, 2022 Jun 30, 2022 10-K/A 2023-10-27
Q1 2022 -$46.5M -$8.73M +$16.9M +65.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$63.4M -$12.2M -$4.13M -51.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-05-11
Q3 2021 -$59.2M -$17.5M -$18.2M -2559% Jul 1, 2021 Sep 30, 2021 10-Q 2023-05-11
Q2 2021 -$41M -$8.06M +$10.4M +56.4% Apr 1, 2021 Jun 30, 2021 10-K/A 2023-10-27
Q1 2021 -$51.4M -$25.6M -$21.3M -492% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$30.1M -$8.03M +$12.2M +60.3% Oct 1, 2020 Dec 31, 2020 10-Q 2022-05-23
Q3 2020 -$42.3M $712K +$3.71M Jul 1, 2020 Sep 30, 2020 10-Q 2022-05-23
Q2 2020 -$46M -$18.5M -$21.5M -705% Apr 1, 2020 Jun 30, 2020 10-K 2020-09-09
Q1 2020 -$24.5M -$4.33M +$13M +75.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$37.5M -$20.2M -$32.2M -268% Oct 1, 2019 Dec 31, 2019 10-Q 2021-05-06
Q3 2019 -$5.27M -$2.99M +$11.5M +79.4% Jul 1, 2019 Sep 30, 2019 10-Q 2021-05-06
Q2 2019 -$16.8M $3.05M +$22.3M Apr 1, 2019 Jun 30, 2019 10-K 2020-09-09
Q1 2019 -$39.1M -$17.4M -$11.4M -192% Jan 1, 2019 Mar 31, 2019 10-K 2020-09-09
Q4 2018 -$27.7M $12M +$18.1M Oct 1, 2018 Dec 31, 2018 10-K 2020-09-09
Q3 2018 -$45.8M -$14.5M -$5.75M -65.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-09-09
Q2 2018 -$40.1M -$19.3M -$14.9M -343% Apr 1, 2018 Jun 30, 2018 10-K 2019-08-28
Q1 2018 -$25.2M -$5.95M -$5.35M -888% Jan 1, 2018 Mar 31, 2018 10-K 2019-08-28
Q4 2017 -$19.8M -$6.08M -$18M -151% Oct 1, 2017 Dec 31, 2017 10-K 2019-08-28
Q3 2017 -$1.85M -$8.79M -$4.52M -106% Jul 1, 2017 Sep 30, 2017 10-K 2019-08-28
Q2 2017 $2.67M -$4.34M +$1.43M +24.7% Apr 1, 2017 Jun 30, 2017 10-K 2018-08-30
Q1 2017 $1.24M -$602K +$4.77M +88.8% Jan 1, 2017 Mar 31, 2017 10-K 2018-08-30
Q4 2016 -$3.53M $11.9M +$17M Oct 1, 2016 Dec 31, 2016 10-K 2018-08-30
Q3 2016 -$20.5M -$4.27M +$350K +7.58% Jul 1, 2016 Sep 30, 2016 10-K 2018-08-30
Q2 2016 -$20.9M -$5.77M -$108K -1.91% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-05
Q1 2016 -$20.8M -$5.37M +$3.56M +39.9% Jan 1, 2016 Mar 31, 2016 10-K 2017-09-05
Q4 2015 -$24.3M -$5.1M +$4.01M +44% Oct 1, 2015 Dec 31, 2015 10-K 2017-09-05
Q3 2015 -$28.3M -$4.62M +$4.37M +48.6% Jul 1, 2015 Sep 30, 2015 10-K 2017-09-05
Q2 2015 -$32.7M -$5.66M +$2.88M +33.7% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-06
Q1 2015 -$35.6M -$8.93M -$1.54M -20.9% Jan 1, 2015 Mar 31, 2015 10-K 2016-09-06
Q4 2014 -$34M -$9.11M -$2.79M -44% Oct 1, 2014 Dec 31, 2014 10-K 2016-09-06
Q3 2014 -$31.2M -$8.99M -$4.1M -83.7% Jul 1, 2014 Sep 30, 2014 10-K 2016-09-06
Q2 2014 -$27.1M -$8.54M -$5.33M -166% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-02
Q1 2014 -$21.8M -$7.39M -$4.63M -168% Jan 1, 2014 Mar 31, 2014 10-K 2015-09-02
Q4 2013 -$17.2M -$6.32M -$3.57M -130% Oct 1, 2013 Dec 31, 2013 10-K 2015-09-02
Q3 2013 -$13.6M -$4.9M -$2.43M -98.7% Jul 1, 2013 Sep 30, 2013 10-K 2015-09-02
Q2 2013 -$11.2M -$3.22M Apr 1, 2013 Jun 30, 2013 10-K 2014-09-09
Q1 2013 -$2.75M Jan 1, 2013 Mar 31, 2013 10-K 2014-09-09
Q4 2012 -$2.75M Oct 1, 2012 Dec 31, 2012 10-K 2014-09-09
Q3 2012 -$2.46M Jul 1, 2012 Sep 30, 2012 10-K 2014-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.